Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
302.00    0.00 (0.00%)
Bid:
299.00
Ask:
306.00
Spread: 7.00 (2.341%)
Market Cap: £180.03m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Response to statement by GAM Holding AG

24 Apr 2023 10:30

RNS Number : 2256X
Liontrust Asset Management PLC
24 April 2023
Β 

DISCLOSURE OF INSIDE INFORMATION ACCORDING TO ARTICLE 17 OF THE UK VERSION OF REGULATION (EU) NO. 596/2014 (WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWL) ACT 2018)

Β 

FOR IMMEDIATE RELEASE

Β 

LIONTRUST ASSET MANAGEMENT PLC

Response to statement by GAM Holding AG

Β 

Further to the announcement of 18 April 2023, Liontrust Asset Management Plc ("Liontrust", or the "Company"), the specialist independent fund management group, notes the announcement made today by GAM Holding AG ("GAM") that on conclusion of the commercial discussions, which includes discussions with Liontrust about a combination of the two firms, within their strategic review, a further update is expected on or prior to 4 May 2023.

Β 

There can be no certainty that this will lead to a formal offer in respect of the proposed acquisition of the entire issued share capital of GAM by Liontrust ("Proposed Acquisition"), nor as to the timing or terms of any such offer, and there can be no assurance that, even if agreement is reached, any such Proposed Acquisition would be completed.

Β 

A further announcement will be made as and when appropriate.

Β 

For further information please contact:

Β 

Teneo (Tel: 020 7353 4200, Email: liontrust@teneo.com)

Tom Murray or Stephanie Mackrell

Β 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

John Ions: Chief Executive

Vinay Abrol: Chief Financial Officer & Chief Operating Officer

Simon Hildrey: Chief Marketing Officer

David Boyle: Head of Corporate Development

Β 

Singer Capital Markets (Tel: 020 7496 3000)

Stephen Howard, Tom Salvesen, Justin McKeegan

Β 

Panmure Gordon (Tel: 020 7886 2500)

Corporate Broking: Stephen Jones

Corporate Advisory: Dominic Morley

Β 

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RSPEAPLLASSDEEA
Date   Source Headline
30th Mar 20267:00 amRNSAppointment of Joint Corporate Broker
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSProposed Acquisition of River Global Holdings Ltd
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20269:36 amRNSTotal Voting Rights
26th Feb 202611:35 amRNSForm 8.3 - ESSENSYS
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20261:28 pmRNSForm 8.3 - ESSENSYS
25th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20262:29 pmRNSForm 8.3 - ESSENSYS PLC
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20262:40 pmRNSForm 8.3 - Kitwave group plc
18th Feb 20262:37 pmRNSForm 8.3 - Oxford Biomedica Plc
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:20 pmRNSForm 8.3 - ESSENSYS PLC
17th Feb 20263:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
16th Feb 20262:51 pmRNSForm 8.3 - Oxford Biomedica Plc
13th Feb 202610:13 amRNSHolding(s) in Company
13th Feb 202610:11 amRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 202611:15 amRNSForm 8.3 - KITWAVE GROUP PLC
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 202612:07 pmRNSForm 8.3 - Kitwave Group Plc
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20263:25 pmRNSForm 8.3 - KITWAVE GROUP PLC
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20262:27 pmRNSForm 8.3 - Kitwave group plc
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20264:36 pmRNSForm 8.3 - MIND GYM PLC
4th Feb 20262:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
4th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.